Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2002
02/07/2002CA2416820A1 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
02/07/2002CA2416810A1 Pharmacokinetic tool and method for predicting metabolism of a compound in a mammal
02/07/2002CA2416807A1 Regional intestinal permeability model
02/07/2002CA2416800A1 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides
02/07/2002CA2416732A1 Endothelial cell expression patterns
02/07/2002CA2415647A1 Neospora caninum isolate
02/07/2002CA2414421A1 Molecular toxicology modeling
02/07/2002CA2412071A1 A device for detecting bacterial contamination and method of use
02/06/2002EP1178315A1 Method and apparatus for examining cells using the patch clamp method
02/06/2002EP1178314A2 Biochemical analysis unit and biochemical analyzing method using the same
02/06/2002EP1178305A2 Spectral calibration of fluorescent polynucleotide separation apparatus
02/06/2002EP1178119A2 A Pcr-based multiplex assay for determining haplotype
02/06/2002EP1178116A1 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof
02/06/2002EP1178115A2 Phosphodiesterase
02/06/2002EP1178109A1 Method for mutagenesis
02/06/2002EP1178053A2 Polypeptides and polynucleotides coding therefor from a family of G-protein coupled receptors and their use for the diagnosis and treatment of skin diseases
02/06/2002EP1177523A1 Histological reconstruction and automated image analysis
02/06/2002EP1177448A2 A combined rapid anti-microbial susceptibility assay and microorganism identification system
02/06/2002EP1177444A1 Process to create biomolecule arrays on metal surfaces
02/06/2002EP1177443A2 A method for measuring biomolecules
02/06/2002EP1177442A1 Determination of complex phospholipid/lipid structures using synthetic fluorescence-marked acylglycerides
02/06/2002EP1177441A1 Cell separation device and methods for use
02/06/2002EP1177423A1 Amplification and separation of nucleic acid sequences using strand displacement amplification and bioelectronic microchip technology
02/06/2002EP1177320A1 Method for specifically detecting and identifying retroviral nucleic acids/retroviruses in an item to be examined
02/06/2002EP1177319A2 Method for detecting microorganisms in a sample
02/06/2002EP1177318A2 Polynucleotide matrix-based method of identifying microorganisms
02/06/2002EP1177317A2 Polynucleotide probes for detection and quantitation of staphylococcus
02/06/2002EP1177316A2 Polynucleotide probes for detection and quantitation of actinomycetes
02/06/2002EP1177315A1 Cell assay, method and reagents
02/06/2002EP1177314A1 Assays for nucleoside diphosphates and triphospates
02/06/2002EP1177313A2 Method for localising proteases which split substrates that are specifically connected by a membrane
02/06/2002EP1177301A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
02/06/2002EP1177296A2 Extracellular matrix and adhesion-associated proteins
02/06/2002EP1177294A1 Novel cellular regulation factor tto 20
02/06/2002EP1177293A1 Growth factor homolog zvegf4
02/06/2002EP1177281A2 Isolation of nucleic acid
02/06/2002EP1177279A1 Assay reagent
02/06/2002EP1177214A1 49 human secreted proteins
02/06/2002EP1177212A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses
02/06/2002EP1177211A2 Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease
02/06/2002EP1177209A1 Compositions of solvents and high concentrations of nucleic acid analogs
02/06/2002EP1177043A2 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification
02/06/2002EP1176989A1 Method for eliminating legionella from a colonized aqueous flux by electropulsation, method for the treatment of an aqueous flux by electropulsation and use thereof in the elimination of legionella
02/06/2002EP1176871A1 Novel beta-secretase and modulation of beta-secretase activity
02/06/2002EP1105457B1 Card for counting and characterising micro-organisms
02/06/2002EP1093459A4 Chemically modified proteins with a carbohydrate moiety
02/06/2002EP1088106A4 Polymerase signaling assay
02/06/2002EP1064389A4 Kinase wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use
02/06/2002EP0871871A4 Improvements in ionic reservoir through application of an electrical potential
02/06/2002EP0866865B1 Chimeric oligomers having an rna-cleavage activity
02/06/2002EP0838027A4 Detection of small analytes
02/06/2002EP0556281B1 A diagnostic assay for lyme disease
02/06/2002CN1334880A Retinol binding protein 4 as genetic marker for increased litter size
02/06/2002CN1334879A Sequencing method using magnifying tags
02/06/2002CN1334878A Polynucleotide comprising ubiquitous chromatin opening element (UCDE)
02/06/2002CN1334875A Cell signalling polypeptides and nucleic acids
02/06/2002CN1334872A Method for immobilizing oligonucleotide on carrier
02/06/2002CN1334871A Method for immobilizing DNA on carrier
02/06/2002CN1334866A Materials and methods for modification of isoprenoid content, composition and metabolism
02/06/2002CN1334820A Connective tissue growth factor fragments and methods and uses thereof
02/06/2002CN1334819A Connective tissue growth factor fragments and methods and uses thereof
02/06/2002CN1334463A Method for identifying cell specific target structure
02/06/2002CN1334460A Biological sensor with porous chromatograph diaphragm
02/06/2002CN1334345A Wall-breaking method of fungus monospore or polyspore for polymerase chain reaction
02/05/2002US6344597 Interspecific nicotiana hybrids and their progeny
02/05/2002US6344552 Compositions and methods comprising DNA sequences encoding B. burgdorferi polypeptides
02/05/2002US6344550 A dna molecule; diagnosing, monitoring and therapy of breast cancer
02/05/2002US6344546 A receptor protein with a cytoplasmic domain having protein kinase activity, a kinase insert, a transmembrane domain and an extracellular domain having three immunoglobulin-like repeats; for drug screening
02/05/2002US6344544 Semaphorin-specific antibodies
02/05/2002US6344542 A polypeptides involved in signal transduction; therapy and diagnosis of cancers, diabetes, obesity, anorexia, asthma, parkinson's disease, heart disease, strokes, allergies, schizophrenia, huntington's disease and tourett's syndrome
02/05/2002US6344475 Cystic fibrosis
02/05/2002US6344441 Lipoprotein-regulating medicaments
02/05/2002US6344440 Antisecretory factor peptides regulating pathological permeability changes
02/05/2002US6344356 Methods for recombining nucleic acids
02/05/2002US6344340 Viability assay for sporocyst-forming protozoa
02/05/2002US6344333 Apparatus for immunological detection of preferential antigen, antibody or hapten
02/05/2002US6344332 Methods for the rapid detection of actively respiring microorganisms
02/05/2002US6344329 Amplification of nucleic acid molecules related to target sequences by ligating the dna to circularize the probe before hybridization, then amplify by rolling circle replication of the probe and detect the target using a reporter molecule
02/05/2002US6344328 Method for screening for enzyme activity
02/05/2002US6344326 Microfluidic method for nucleic acid purification and processing
02/05/2002US6344323 Preventing cyclooxygenase-2 expression using antisense oligonucleotides that bind polynucleotides encoding cyclooxygenase; therapy for arthritis, ulcers, inflammatory bowel disease, multiple sclerosis, and alzheimer's disease
02/05/2002US6344322 Subtle mitochondrial mutations as tumor markers
02/05/2002US6344321 Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met
02/05/2002US6344319 Determining copy numbers of genomic dna that has been aligned on a surface using molecular combing techniques, reacting the aligned dna with specific probes for controled genomic sequences and detect hybridization and calculate copy numbers
02/05/2002US6344318 A selex method determining three dimensional structure of nucleic acid ligands by identifying a ligand to a specific target and modifying the nucleotides with a monomer to allow the ligand to mimic the structure and bind the target
02/05/2002US6344317 Contacting a biological sample from a patient with a nucleic acid which specifically hybridizes to a target human nucleic acid sequence and detecting the presence of the target sequence; diagnosis of chronic illness such as cancer
02/05/2002US6344316 Nucleic acid analysis techniques
02/05/2002US6344315 Staining targeted interphase chromosomes using in situ hybridization and unique nucleic acid probes greater than 50,000 bases
02/05/2002US6344314 Determined DNA sequenced derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
02/05/2002US6344201 Inhibitors of e. coli and shigella enterotoxins; used for drugs and dna vaccines
02/05/2002CA2231475C Universal spacer/energy transfer dyes
02/05/2002CA2078006C Multichromophore fluorescent probes
02/05/2002CA2006473C Improved anti-infective therapy
02/04/2002CA2354253A1 Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances
02/01/2002WO2001007617A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity
02/01/2002CA2380942A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity
01/2002
01/31/2002WO2002009012A2 Accessibility correction factors for electronic models of cytochrome p450 metabolism
01/31/2002WO2002008965A2 Method for determining spatial distances in polymers
01/31/2002WO2002008765A2 Basal cell markers in breast cancer and uses thereof
01/31/2002WO2002008764A1 Detection of abnormalities leading to cervical malignancy